Diabetes is not treated as a coronary artery disease risk equivalent

Diabetes Care

Volumn 30, Issue 2, 2007, Pages 381-383

  Shah, Baiju R ^a   Hux, Janet E ^a   Austin, Peter C ^a  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SECONDARY PREVENTION;

ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; COHORT STUDIES; CORONARY DISEASE; DATABASES, FACTUAL; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; HUMANS; ONTARIO; RISK FACTORS;

EID: 33846671763     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1654     Document Type: Article

References (23)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
2. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J, the Multiple Risk Factor Intervention Trial Research Group: Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 164:1438-1443, 2004
3. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. Diabetes Care 28:2901-2907, 2005
4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Choleserol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Washington, DC, National Institutes of Health, 2002, (NIH publ. no. 02-5215)
5. National High Blood Pressure Education Program: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Washington, DC, National Institutes of Health, 2004, (NIH publ. no. 04-5230)
6. American Diabetes Association: Standards of medical care in diabetes-2006. Diabetes Care 29 (Suppl. 1):S4-S42, 2006
7. International Diabetes Federation Clinical Guidelines Taskforce: Global Guideline for Type 2 Diabetes. Brussels, International Diabetes Federation, 2005
8. McPherson R, Frohlich J, Fodor G, Genest J, the Canadian Cardiovascular Society: Canadian Cardiovascular Society position statement: recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 22:913-927, 2006
9. Feldman RD, Campbell N, Larochelle P, Bolli P, Burgess ED, Carruthers SG, Floras JS, Haynes RB, Honos G, Leenen FH, Leiter LA, Logan AG, Myers MG, Spence JD, Zarnke KB: 1999 Canadian recommendations for the management of hypertension. CMAJ 161 (Suppl.):S1-S17, 1999
10. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25:512-516, 2002
11. Austin PC, Daly PA, Tu JV: A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 144:290-296, 2002
12. Petersen LA, Wright S, Normand SL, Daley J: Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med 14:555-558, 1999
13. Jackevicius CA, Mamdani M, Tu JV: Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288:462-467, 2002
14. Wolff AM, Taylor SA, McCabe JF: Using checklists and reminders in clinical pathways to improve hospital inpatient care. Med J Aust 181:428-431, 2004
15. Biviano AB, Rabbani LE, Paultre F, Hurley E, Sullivan J, Giglio J, Mosca L: Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines. Am J Cariol 91:1248-1250, 2003
16. Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA: Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ 171:1189-1192, 2004
17. Elad Y, French WJ, Shavelle DM, Parsons LS, Sada MJ, Every NR: Primary angioplasty and selection bias in patients presenting late (>12 h) after onset of chest pain and ST elevation myocardial infarction. J Am Coll Cardiol 39:826-833, 2002
18. Krumholz HM, Radford MJ, Ellerbeck EF, Hennen J, Meehan TP, Petrillo M, Wang Y, Jencks SF: Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med 124:292-298, 1996
19. Ko DT, Mamdani M, Alter DA: Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 291:1864-1870, 2004
20. Rasmussen JN, Gislason GH, Abildstrom SZ, Rasmussen S, Gustafsson I, Buch P, Friberg J, Kober L, Torp-Pedersen C, Madsen M, Stender S: Statin use after acute myocardial infarction: a nationwide study in Denmark. Br J Clin Pharmacol 60:150-158, 2005
21. Stone PH, Thompson B, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, Diver DJ, Theroux P, Warnica JW, Nasmith JB, Kells C, Kleiman N, McCabe CH, Schactman M, Knatterud GL, Braunwald E: Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III registry. JAMA 275:1104-1112, 1996
22. Krumholz HM, Murillo JE, Chen J, Vaccarino V, Radford MJ, Ellerbeck EF, Wang Y: Thrombolytic therapy for eligible elderly patients with acute myocardial infarction. JAMA 277:1683-1688, 1997
23. Ramsay SE, Morris RW, Papacosta O, Lennon LT, Thomas MC, Whincup PH: Secondary prevention of coronary heart disease in older British men: extent of inequalities before and after implementation of the National Service Framework. J Public Health (Oxf) 27:338-343, 2005